Peter Alff

President at Opera Therapeutics, Inc.

Health Technology

Profile

Peter Alff has held director positions at Actinobac Biomed, Symbiotix Biotherapies, and Opera Therapeutics.
He currently holds positions as Director at Actinobac Biomed and Symbiotix Biotherapies, and as President & Director at Opera Therapeutics.

Peter Alff active positions

Companies	Position	Start
Actinobac Biomed, Inc. Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ.	Director/Board Member	-
Opera Therapeutics, Inc. Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY.	President	-
Symbiotix Biotherapies, Inc. Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA.	Director/Board Member	-

All active positions of Peter Alff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Alff's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Actinobac Biomed, Inc. Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ.	Health Technology
Opera Therapeutics, Inc. Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY.	Health Technology
Symbiotix Biotherapies, Inc. Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA.	Health Technology

See company connections